InNexus Biotechnology Inc.

February 21, 2008 - 4:00 PM Eastern
InNexus Announces Pre-Clinical Candidate Targeting Breast Cancer (DXL702)

 
Information contained in this webcast is current as of the date and time first presented.
 
Related Events (times are Eastern)Date/Time
Investor Update Conference Call     
Royalty Pharma Update Conference Call     
Webcast Outlining Recently Launched Pre-Clinical Candidate DXL625 (CD20)    
 
Show times in :